Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...

書誌詳細
主要な著者:	Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
フォーマット:	論文
言語:	English
出版事項:	MDPI AG 2020-12-01
シリーズ:	Vaccines
主題:	RNA vaccines mRNA vaccines saRNA vaccines pandemic-response vaccine production COVID-19 production process modelling
オンライン･アクセス:	https://www.mdpi.com/2076-393X/9/1/3

類似資料

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
著者:: Robin John Shattock, 等
出版事項: (2023-11-01)

Vaccines’ New Era-RNA Vaccine
著者:: Wenshuo Zhou, 等
出版事項: (2023-08-01)

Advancing mRNA technologies for therapies and vaccines: An African context
著者:: Dylan Kairuz, 等
出版事項: (2022-10-01)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
著者:: Bruna Aparecida Souza Machado, 等
出版事項: (2021-11-01)

Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
著者:: Janne Snoeck, 等
出版事項: (2023-11-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
著者:: Reese Jalal Ladak, 等
出版事項: (2022-05-01)

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
著者:: Yalan Liu, 等
出版事項: (2023-06-01)

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
著者:: Alexey D. Perenkov, 等
出版事項: (2023-10-01)

Editorial: RNA vaccines for prevalent and newly emerging diseases
著者:: César López-Camacho, 等
出版事項: (2024-08-01)

Development of mRNA rabies vaccines
著者:: Zixin Fang, 等
出版事項: (2024-12-01)

A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice
著者:: Paul K. Kitandwe, 等
出版事項: (2024-09-01)

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines
著者:: Dylan Kairuz, 等
出版事項: (2023-04-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
著者:: Min Tang, 等
出版事項: (2023-04-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
著者:: Ziqi Cheng, 等
出版事項: (2024-12-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
著者:: Karuna M. Das, 等
出版事項: (2022-04-01)

RNA-based vaccines – types, strategies of delivery and overview of RNA vaccines
著者:: Barbara Rusinowska, 等
出版事項: (2022-08-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
著者:: Qi Ma, 等
出版事項: (2025-01-01)

An mRNA vaccine against rabies provides strong and durable protection in mice
著者:: Miao Li, 等
出版事項: (2023-10-01)

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
著者:: Shehzad M. Iqbal, 等
出版事項: (2024-08-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
著者:: Amparo L. Figueroa, 等
出版事項: (2025-12-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
著者:: Alireza Shariati, 等
出版事項: (2024-12-01)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
著者:: Chiranjib Chakraborty, 等
出版事項: (2021-07-01)

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
著者:: Mohammad Natami, 等
出版事項: (2024-03-01)

Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
著者:: Enikő Bárczi, 等
出版事項: (2022-08-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
著者:: Albert Liu, 等
出版事項: (2022-07-01)

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines
著者:: Teresa Aydillo, 等
出版事項: (2024-12-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
著者:: Girolamo Giannotta, 等
出版事項: (2023-03-01)

Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
著者:: Emanuele Amodio, 等
出版事項: (2022-03-01)

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development
著者:: Emma N. Welbourne, 等
出版事項: (2024-03-01)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
著者:: Andrei A. Deviatkin, 等
出版事項: (2022-04-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
著者:: Md. Motiar Rahman, 等
出版事項: (2021-03-01)

Editorial: Building public confidence in innovative mRNA vaccines
著者:: Jia Hu, 等
出版事項: (2025-01-01)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
著者:: Vivek P. Chavda, 等
出版事項: (2023-02-01)

Advances in nucleic acid-based cancer vaccines
著者:: Hung-Chun Liao, 等
出版事項: (2025-01-01)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
著者:: Yu-Jing Fan, 等
出版事項: (2021-09-01)

A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals
著者:: Ann Lisa Arulappen, 等
出版事項: (2022-05-01)

Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
著者:: Zoltán Kis
出版事項: (2022-02-01)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
著者:: Dimitri Papukashvili, 等
出版事項: (2022-10-01)

Dendrimer-Mediated Delivery of DNA and RNA Vaccines
著者:: Lyubov A. Kisakova, 等
出版事項: (2023-03-01)

mRNA Technology and Mucosal Immunization
著者:: Antonio Toniolo, 等
出版事項: (2024-06-01)